홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Piperidine → Ether hydrochloride

HRID 849406
인쇄

반응식

HRID 849406 반응식
[C:1]([N:8]1[CH:12]=[CH:11]N=[CH:9]1)(N1[CH:7]=[CH:6]N=C1)=[O:2].[ClH:13].Cl.[NH:15]1[CH:19]=[C:18]([CH2:20][N:21]2[C:27]3[CH:28]=[C:29]([NH2:32])[CH:30]=[CH:31][C:26]=3[CH2:25][N:24]([C:33]([C:35]3[C:44]4[C:39](=[CH:40][CH:41]=[CH:42][CH:43]=4)[CH:38]=[CH:37][CH:36]=3)=[O:34])[CH2:23][CH2:22]2)[N:17]=[CH:16]1.[CH2:45](N(CC)CC)[CH3:46].N1CCCCC1>C(Cl)Cl.C([O-])(O)=O.[Na+].C(Cl)(Cl)Cl>[ClH:13].[ClH:13].[NH:15]1[CH:19]=[C:18]([CH2:20][N:21]2[C:27]3[CH:28]=[C:29]([NH:32][C:1]([N:8]4[CH2:9][CH2:46][CH2:45][CH2:11][CH2:12]4)=[O:2])[CH:30]=[CH:31][C:26]=3[CH2:25][N:24]([C:33]([C:35]3[C:44]4[C:39](=[CH:40][CH:41]=[CH:42][CH:43]=4)[CH:38]=[CH:37][CH:36]=3)=[O:34])[CH2:23][CH2:22]2)[N:17]=[CH:16]1.[ClH:13].[CH3:6][CH2:7][O:34][CH2:33][CH3:35]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 4

HCID 8082PiperidineHCID 8471TriethylamineHCID 682631,1'-CarbonyldiimidazoleHCID 1784786502,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(1-naphthalenylcarbonyl)-8-amino-1H-1,4-benzodiazepine, dihydrochloride

생성물 2

HCID 10953452Ether hydrochloride
HCID 178478887
N-[2,3,4,5-Tetrahydro-1-(1H-imidazol-4-ylmethyl)-4-(1-naphthalenylcarbonyl)-1H-1,4-benzodiazepin-8-yl]-1-piperidinecarboxamide, dihydrochloride

시약·촉매·용매 3

HCID 6212Chloroform용매HCID 6344Dichloromethane용매HCID 516892Sodium Bicarbonate용매

실험 절차

Carbonyidiimidazole (0.045 g, 0.137 mmol), was added to a solution of Example 26 (0.050 g, 0.125 mmol), and triethylamine (0.038 mL, 0.275 mmol) in dry methylene chloride (1 mL) at rt under argon. After stirring for 2 hr, piperidine (0.013 mL, 0.13 mmol) was added. After stirring for 15 hr, the reaction was diluted with NaHCO3 and CHCl3. The organic layer was washed with NaHCO3, water, and brine (1×3 mL each), dried over MgSO4, filtered and concentrated. The product was purified by reverse phase HPLC with a gradient of 40-90% aquous methanol with 0.1% TFA and the HCl salt was formed by treatment with 1M HCl/ether to afford Example 247 (0.006 g, 10%).

후처리

  1. stirringAfter stirring for 15 hr
  2. washThe organic layer was washed with NaHCO3, water, and brine (1×3 mL each)
  3. dry with materialdried over MgSO4
  4. filtrationfiltered
  5. concentrationconcentrated
  6. customThe product was purified by reverse phase HPLC with a gradient of 40-90% aquous methanol with 0.1% TFA

출처 및 근거

ORD 기록
ord-2139a2414ebb49b38fba161beabdfbc8
출처 데이터셋
uspto-grants-2000_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06011029

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트